![Oncopeptides, Audiocast with teleconference, Q2'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/c157e3ee-2c3d-4254-93cf-c802cf91837d.png)
Log in to your Inderes Free account to see all free content on this page.
Oncopeptides
2.49 SEK -0.4%1 investor is following this company
Oncopeptides is a biotech company that develops drugs for difficult-to-treat hematological diseases. The company uses its PDC platform to develop peptide-linked drugs that selectively deliver cytotoxic drugs into cancer cells. The company has drugs in commercialization and several drug candidates under development. Oncopeptide's head office is located in Stockholm.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
ONCO
Daily low / high price
2.47 / 2.55
SEK
Market cap
535.81M SEK
Turnover
1.15M SEK
Volume
458K
Latest videos
Financial calendar
Interim report
14.08.2024
Interim report
07.11.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
HealthCap VIII L.P. | 12.7 % | 12.9 % |
Avanza Pension | 7.9 % | 8.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
![Oncopeptides, Audiocast with teleconference, Q2'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/c157e3ee-2c3d-4254-93cf-c802cf91837d.png)
First patient enters Oncopeptides study aiming to gain real-world insights from Pepaxti in Germany
Number of shares and votes in Oncopeptides
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Oncopeptides selects first candidate drug from its SPiKE platform
Bulletin from the Annual General Meeting in Oncopeptides AB (publ)
Number of shares and votes in Oncopeptides
![Oncopeptides, Audiocast with teleconference, Q1'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/23d2417d-1e9d-42db-991d-bf5d3bdd2ec0.png)